Upcoming Summits
Building a Solid Threat Detection and Response Program
Threat detection and response is an ever-present need as cyber attacks grow more sophisticated and sneakier with each passing year. Fortunately, emerging
technology helps companies modernize threat detection efforts to spot attacks and prevent the devastating fallout. As of 2025, the United States governme…
Data-Driven Strategies in the AI Age
TechTarget’s Enterprise Strategy Group's report, "The State of Analytics and Business Intelligence Platforms," revealed that AI technologies, both traditional
and generative, are considered important to more than 95% of organizations. This high rating puts AI at the forefront of enterprise technology strategies a…
Enforcing Security with Zero Trust
Digital transformation has positioned zero trust as the first line of defense against a multiplex threat landscape. Zero trust is multi-faceted and, if leveraged
correctly, can keep up with evolving threats using identity management, multi-factor authentication, AI and machine learning. Despite the many zero trust …
Enhancing the CX Journey for Maximum Success
The rise of digital channels has fragmented customer interactions, making it harder to deliver a consistent and personalized brand across all touchpoints. At
the same time, the surge of customer data is overwhelming traditional analytics, leaving organizations struggling to extract actionable insights and missing …
Comprehensive Strategies for Data Protection
We live in a world where data is both essential and risky, so staying on top of data protection practices is critical. Attend our virtual Summit and discover
strategies and methods to help you keep your organization’s sensitive information safe and in compliance with changing laws and regulations. Join your pe…
GLP-1 Innovation and Oversight Shaping the Future of Therapeutic Access
GLP-1 receptor agonists have become blockbuster therapies for obesity and diabetes and are now being explored for broader use across various health
conditions. Yet the rapid growth of compounded versions, often produced without FDA oversight, presents serious safety and compliance risks. This Summi…